For years, the life sciences industry has relied on a rigid, document-heavy process called Computer System Validation (CSV). The goal was to prove that a computer system worked as intended, but it often devolved into a 'tick-box' exercise. Teams would generate mountains of paperwork to satisfy auditors, sometimes losing sight of the ultimate purpose: ensuring patient safety and product quality.

The industry recognized this wasn't sustainable. In 2022, the ISPE released GAMP 5, Second Edition, signaling a major philosophical shift. It championed a more modern, risk-based approach known as Computer Software Assurance (CSA).

Instead of asking, "Have we produced the right documents?" CSA asks, "Are we confident this software is fit for its intended purpose?" This new mindset is built on a foundation of critical thinking and is guided by five core principles.

The second edition of GAMP 5 isn't a complete overhaul, but a refinement. It codifies the shift towards critical thinking through five interconnected principles. These principles guide organizations to build quality into their systems from the start, rather than trying to test it in at the end.

1. Product and Process Understanding: You can't validate what you don't understand. This principle emphasizes the need for a deep knowledge of the product being made and the process used to make it. Only then can you accurately assess the risks associated with a computer system.

2. Lifecycle Approach within a Quality Management System (QMS): Validation isn't a one-time event. It's a continuous process that spans the entire lifecycle of a system, from initial concept to retirement. All activities must be managed within the framework of the company's existing QMS, ensuring consistency and control.

3. Scalable Lifecycle Activities: Not all systems are created equal. The level of effort and documentation for validation should be proportional to the system's risk, complexity, and novelty. A simple, off-the-shelf tool doesn't require the same rigorous validation as a complex, custom-built manufacturing execution system.

4. Science-Based Quality Risk Management: This is the heart of CSA. All decisions should be driven by a formal risk management process. This means identifying potential hazards, assessing their risk to patient safety and product quality, and focusing assurance efforts on mitigating the highest risks. It's about being effective, not just busy.

5. Leveraging Supplier Involvement: Modern systems are rarely built from scratch. Organizations should leverage the testing and documentation already performed by their software suppliers. This could include vendor audits, reviewing their quality processes, or using their qualification documents as a starting point. It's about working smarter, not harder.

The move to CSA requires a cultural shift. It empowers teams to use their professional judgment. Instead of blindly following a prescriptive validation plan, they are expected to think critically about potential risks. This means less time on unscripted, low-risk testing and more time on activities that truly assure quality and safety.

For example, under the old CSV model, a team might spend hours writing and executing test scripts for a feature like changing the color of a button on a user interface. With CSA, the team would identify this as a low-risk feature with no impact on the patient or product. They might verify it works with a quick, unscripted check and move on, dedicating their resources to testing a critical calculation engine or data logging feature instead.

This risk-based approach doesn't mean less rigor; it means applying rigor where it counts. The goal is to build confidence and provide objective evidence that the software is fit for purpose, protecting both the patient and the business.

Time to see what you've learned about these modern principles.